Versatope awarded up to $17.9M to develop a universal influenza vaccine using extracellular bacterial vesicles

October 24, 2019 Leave a comment 903 Views

Versatope Therapeutics, Inc., a biotechnology company developing vaccines and therapeutics, announced today that it has been awarded a contract with National Institute of Allergy and Infectious...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: NIAID

Versatope awarded up to $17.9M to develop a universal influenza vaccine using extracellular bacterial vesicles

Development of a simple, sensitive and selective colorimetric aptasensor for the detection of cancer-derived exosomes

miR Scientific announces FDA breakthrough device designation for its prostate cancer liquid biopsy test

Could A Nasal Spray Of “Nanovesicles” Repair Brain Cells?

Isolation of exosomes from whole blood by a new microfluidic device

MDimune’s BioDrone platform technology based on cell-derived vesicles received “Best Cell Therapy Technology of the Year” award at Cell Therapy World Asia 2020

Researchers identify how exosomes cause internal clock confusion in night-shift workers